Kathleen Larrimer Beckmann
Plus aucun poste en cours
Profil
Kathleen Larrimer Beckmann served as the Chief Financial Officer at Arch Oncology, Inc. She received her undergraduate degree from Princeton University in 1985 and her MBA from Stanford Graduate School of Business in 1991.
Anciens postes connus de Kathleen Larrimer Beckmann
Sociétés | Poste | Fin |
---|---|---|
Arch Oncology, Inc.
Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Directeur Financier/CFO | - |
Formation de Kathleen Larrimer Beckmann
Stanford Graduate School of Business | Masters Business Admin |
Princeton University | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Arch Oncology, Inc.
Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Commercial Services |